Cargando…
Human disease models in drug development
Biomedical research is undergoing a paradigm shift towards approaches centred on human disease models owing to the notoriously high failure rates of the current drug development process. Major drivers for this transition are the limitations of animal models, which, despite remaining the gold standar...
Autores principales: | Loewa, Anna, Feng, James J., Hedtrich, Sarah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10173243/ https://www.ncbi.nlm.nih.gov/pubmed/37359774 http://dx.doi.org/10.1038/s44222-023-00063-3 |
Ejemplares similares
-
3D organ models—Revolution in pharmacological research?
por: Weinhart, Marie, et al.
Publicado: (2019) -
Small, Cationic Antifungal Proteins from Filamentous Fungi Inhibit Candida albicans Growth in 3D Skin Infection Models
por: Holzknecht, Jeanett, et al.
Publicado: (2022) -
COVID-19 highlights the model dilemma in biomedical research
por: Adhikary, Partho Protim, et al.
Publicado: (2021) -
Gene Delivery to the Skin – How Far Have We Come?
por: Ain, Qurrat Ul, et al.
Publicado: (2021) -
Human organs-on-chips for disease modelling, drug development and personalized medicine
por: Ingber, Donald E.
Publicado: (2022)